Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,209.27 +37.12 (+0.45%) Bitcoin USD
61,648.47 +2,593.58 (+4.39%) CMC Crypto 200
1,329.43 +52.45 (+4.11%)
SNY May 2024 47.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:22AM EDT. Market open.
| Previous close | 0.7800 |
| Open | 1.1000 |
| Bid | 0.1000 |
| Ask | 2.9000 |
| Strike | 47.50 |
| Expiry date | 2024-05-17 |
| Day's range | 0.1500 - 1.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 279 |
Insider MonkeyRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
- Thomson Reuters StreetEvents
Q1 2024 Kymera Therapeutics Inc Earnings Call
Q1 2024 Kymera Therapeutics Inc Earnings Call
ZacksRegeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Regeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.
© 2024 Yahoo. All rights reserved.